Arquivos do dia: Junho 8, 2021
Condições médicas subjacentes associadas à COVID-19 grave em crianças – Os principais fatores de risco para hospitalização foram doenças crônicas e complexas, diabetes tipo 1 e obesidade.
8 Jun, 2021 | 10:31hComentários: Underlying illness, respiratory infection raise risk for severe COVID in kids – CIDRAP E COVID-19 in Children—Not Just Little Adults – JAMA Network Open
Comentário no Twitter
This cross-sectional study found a higher risk of severe #COVID19 illness among children with medical complexity and certain underlying conditions, such as type 1 diabetes, cardiac and circulatory congenital anomalies, and obesity. https://t.co/ifq1Ao0HKS
— JAMA Network Open (@JAMANetworkOpen) June 7, 2021
Pequena revisão | Complicações neurológicas da COVID-19.
8 Jun, 2021 | 10:30hNeurological complications of COVID-19 – Intensive Care Medicine
Comentário no Twitter
NeuroCOVID potential mechanism(s)?
🧠 #COVID19 neuro-complications
🧠 direct neuroinvasion
🧠 inflammatory/autoimmune
🧠 vascular
+
🧠 #ICU complications
🧠 drugs toxicity/side effects
🧠 PICS/PACS & PTSD
Challenging to identify/diagnose: strictly monitor! https://t.co/0YlAoanUFo pic.twitter.com/unM0SWFR7L— Intens Care Med (@yourICM) June 7, 2021
“Fungo negro” na Índia: o surgimento de uma síndrome endêmica de mucormicose associada a COVID-19 – Uso cauteloso de antibióticos e corticosteroides e monitoramento constante dos níveis de glicemia são algumas das estratégias sugeridas pelos autores.
8 Jun, 2021 | 10:29hEstudo epidemiológico multicêntrico da mucormicose associada a Covid, Índia – Diabetes melito descontrolada foi a doença de base mais comum; uso inadequado de glicocorticoide foi independentemente associado com a doença.
8 Jun, 2021 | 10:28hComentário: COVID19: Secondary Infections Still a Big Challenge in India – News Click
Comentário no Twitter
New study from India on mucormycosis
– COVID-19 has led to increases in mucormycosis, partly from inappropriate steroid use
– Uncontrolled diabetes was the most common underlying disease
Better diabetes care & rational steroid use are key!https://t.co/Wv8kCyTDtK pic.twitter.com/KK78BKg2Xf
— Madhu Pai, MD, PhD (@paimadhu) June 7, 2021
“Challenge Trials” com SARS-CoV-2 são éticos? – “Um ensaio clínico realizado no Reino Unido está expondo deliberadamente participantes jovens e saudáveis ao SARS-CoV-2 para avaliar a inoculação viral necessária para produzir infecção e testar a eficácia de vacinas.”
8 Jun, 2021 | 10:27hAre SARS-CoV-2 Human Challenge Trials Ethical? – JAMA Internal Medicine
Relacionado: World’s first coronavirus “Human Challenge” study receives ethics approval in the UK (vários textos sobre o assunto)
Comentário no Twitter
I am not convinced of #SARSCoV2 #ChallengeTrials. You should not pay volunteers. If things go wrong, there is no effective treatment. What will be learnt from mild disease, when you are interested in severe disease? #COVID19 #Covid #Corona #coronavirushttps://t.co/JjXDJDfOl2
— Martin Michaelis (@MartMichaelis) June 8, 2021
Relato | 376.000 pessoas no Reino Unido tiveram sintomas de “long Covid” por, pelo menos, 1 ano.
8 Jun, 2021 | 10:25h376,000 people in UK have had long Covid symptoms for at least a year – ONS – The Guardian
Relatório original: Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 4 June 2021 – Office for National Statistics
Valor das manifestacões cutâneas no diagnóstico pelo SARS-CoV-2 – Houve uma associação significativa entre rash cutâneo e teste positivo (odds ratio 1,67).
8 Jun, 2021 | 10:24hDiagnostic value of cutaneous manifestation of SARS-CoV-2 infection – British Journal of Dermatology
Prática | Acne relacionada ao uso de máscara (“mascne”) e outras dermatoses faciais.
8 Jun, 2021 | 10:24hMask related acne (“maskne”) and other facial dermatoses – The BMJ
Comentário no Twitter
The term “maskne” has become increasingly popular during the pandemic, particularly in the media.
This #BMJInfographic presents common distributions that can be used as a starting point for assessment @will_s_t https://t.co/mKQUaN3PYY pic.twitter.com/OCBuFxiY9s
— The BMJ (@bmj_latest) June 7, 2021
Sinopse | Atualizações das diretrizes de tratamento da asma pediátrica.
8 Jun, 2021 | 10:22hUpdates to the Pediatrics Asthma Management Guidelines – JAMA Pediatrics (gratuito por tempo limitado)
Tempo para positividade em infecção da corrente sanguínea não é um marcador prognóstico de mortalidade: análise de um estudo prospectivo multicêntrico, controlado e randomizado.
8 Jun, 2021 | 10:21h
Comentário no Twitter
🆕💥Analysis Data from RAPIDO RCT
Time to positivity is not associated with mortality, except in Candida spp (longer times associated with worse outcomes), and possibly in Streptococci (shorter times associated with worse outcomes) #IDTwitter #medtwitter https://t.co/v17uT8j7u9— Antibiotic Steward 🇵🇸💔Bassam Ghanem (@ABsteward) June 7, 2021